CAS 892664-04-9

GSK 269984a

CAS : 892664-04-9

GSK 269984a is a novel, selective, orally available, non-steroidal anti-inflammatory drug that was discovered by the medicinal chemistry team of GlaxoSmithKline (GSK). It acts as an antagonist at the EP1 receptor and has shown efficacy in reducing inflammatory pain in human subjects. GSK 269984a is currently undergoing clinical development to determine its optimal dosage and safety profile.

Formule : C₂₀H₁₃Cl₂FNNaO₃

Degré de pureté : Min. 95%

Masse moléculaire : 428.2 g/mol

Ref: 3D-SKB66404

GSK-269984A

CAS : 892664-04-9

GSK-269984A is an antagonist of Prostaglandin E2 Receptor 1 (EP1) (pIC50: 7.9).

Formule : C₂₀H₁₄Cl₂FNNaO₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 429.22

Ref: TM-T15421